Mitochondria‐targeted temozolomide (mtTmz) using peptide‐based delivery vector has been shown to overcome direct DNA repair and resistance by O6‐methylgunaine DNA methyltransferase (MGMT) in glioblastoma (GBM) cells. This evidence concerns the gene MGMT and glioblastoma.